Replay
About:
Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
Website: https://replay.bio/
Twitter/X: replaybio
Top Investors: Kohlberg Kravis Roberts, Artis Ventures (AV), OMX Ventures, Lansdowne Partners, Axial VC
Description:
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.
Total Funding Amount:
$55M
Headquarters Location:
San Diego, California, United States
Founded Date:
2021-01-01
Contact Email:
info(AT)replay.bio
Founders:
Adrian Woolfson, Lachlan MacKinnon
Number of Employees:
11-50
Last Funding Date:
2022-07-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai